HUMAN PLATELET LYSATE (hPL)

Human Platelet Lysate (hPL) is a cell culture growth supplement obtained from human platelets. Human Platelet Lysate contains abundant growth factors and cytokines necessary for cell growth and proliferation. Replacing foetal bovine serum (FBS) with Human Platelet Lysate allows for expansion and potential clinical grade production of functional mesenchymal stromal cells by removing the risk of xenogeneic immune reactions and transmission of bovine prion and viral pathogens.

European guidelines require that bovine material should be removed from culturing media wherever possible for any therapeutic product containing cultured cells. Human Platelet Lysate is a suitable alternative for use in R&D and production/manufacturing processes.

Human Platelet Lysate (hPL) products:

ELAREM™

ELAREM™

ELAREM™ products. Human Platelet Lysate from Research to GMP Grade. Some require the addition of heparin prior to use. This product line includes ELAREM Prime, Perform, Perform-FD, Ultimate-FDi and Matrix Kit.

Find out more >

Standard hPL

Standard hPL

Requires the addition of heparin prior to use. Available as both Research and GMP Grade.

Find out more >

Fibrinogen Depleted hPL

Fibrinogen Depleted hPL

A fibrinogen-depleted human platelet lysate that does not require the addition of heparin prior to use. For human ex-vivo tissue and cell culture processing applications.

Find out more >

Xeno Free hPL

Xeno Free hPL

A completely xeno-free (animal-component free), fibrinogen-depleted human platelet lysate. No heparin supplementation is required. For human ex-vivo tissue and cell culture processing applications.

Find out more >